Skip to main content
Elsevier
View Cart
My account

Books in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

BooksJournals

    • Annual Reports in Medicinal Chemistry

      • 1st Edition
      • Volume 33
      • August 11, 1998
      • James A. Bristol + 5 more
      • English
      • Paperback
        9 7 8 0 1 2 0 4 0 5 3 3 6
      • eBook
        9 7 8 0 0 8 0 5 8 3 7 7 8
      Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expectedto provide the basis for entirely new future therapies.

    • Advances in Pharmacology

      • 1st Edition
      • Volume 44
      • March 18, 1998
      • English
      • Paperback
        9 7 8 0 1 2 3 9 1 7 5 8 4
      • Hardback
        9 7 8 0 1 2 0 3 2 9 4 5 8
      • eBook
        9 7 8 0 0 8 0 5 8 1 3 6 1
      Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular bases of drug action, both applied and experimental.

    • Diuretic Agents

      • 1st Edition
      • September 4, 1997
      • Donald W. Seldin + 1 more
      • English
      • Hardback
        9 7 8 0 1 2 6 3 5 6 9 0 8
      • eBook
        9 7 8 0 0 8 0 5 3 0 4 6 8
      The only comprehensive work to cover all aspects of diuretic agents, the book discusses the pharmacology and toxicology of diuretic agents as well as the physiological effects. Experts in the field present the principles and experimental approaches for the study of interactions between pharmacologic compounds in relation to specific target organs. Diuretic Agents contains information on the mechanisms of action and application of diuretics, and details FDA regulations and pharmaceutical industry guidelines.

    • Advances in Pharmacology

      • 1st Edition
      • Volume 39
      • June 2, 1997
      • English
      • eBook
        9 7 8 0 0 8 0 5 8 1 3 1 6
      Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular bases of drug action, both applied and experimental.

    • Advances in Drug Research

      • 1st Edition
      • Volume 30
      • August 12, 1997
      • English
      This volume continues the trend for Advances in Drug Research of shorter, but more frequent volumes. In line with the tradition of the series, chapters on general themes are interspersed with chapters on specific drug classes and targets. It will be the last volume edited by Bernard Testa and Urs A. Meyer.

    • Heparin-Binding Proteins

      • 1st Edition
      • September 19, 1997
      • H. Edward Conrad
      • English
      • Hardback
        9 7 8 0 1 2 1 8 6 0 6 0 8
      • eBook
        9 7 8 0 0 8 0 5 3 3 9 0 2
      This book describes the complex structures of heparins and heparan sulfates (heparinoids) and how they are generated by their biosynthetic pathways. The book also details the methodologies for studying these structures and their cellular metabolism. Heparin-Binding Proteins introduces the general nature of interactions between heparinoids and proteins, and presents the role for these structures in their interactions with the proteins of the hemostatic mechanisms, fibroblasts growth factors, superoxide dismutase, and lipoproteins.

    • Elsevier's Dictionary of Drug Traffic Terms

      • 1st Edition
      • May 9, 1997
      • N. Illanes
      • English
      • Hardback
        9 7 8 0 4 4 4 8 1 9 3 7 6
      • eBook
        9 7 8 0 0 8 0 5 7 0 1 5 0
      This dictionary provides fast and easy access to terms in areas such as: legal, judicial and court proceedings; law enforcement, police and military training; chemical essentials and chemical precursors; natural, synthetic and designer drugs; banking and money laundering. It also presents some related terminology for environmental, medical, psychological, social and economic matters. The dictionary includes a large number of jargon terms, and explanations of these have been provided in some cases, in order to ensure better understanding. This work is an indispensable tool for conference interpreters, court interpreters, translators and social workers.

    • Advances in Drug Research

      • 1st Edition
      • Volume 29
      • July 21, 1997
      • English
      • Hardback
        9 7 8 0 1 2 0 1 3 3 2 9 1
      • eBook
        9 7 8 0 0 8 0 5 2 6 7 2 0
      This volume continues the trend for Advances in Drug Research of shorter, but more frequent volumes. In line with the tradition of the series, chapters on general themes are interspersed with chapters on specific drug classes and targets.

    • Drug-Drug Interactions: Scientific and Regulatory Perspectives

      • 1st Edition
      • Volume 43
      • October 2, 1997
      • English
      • Hardback
        9 7 8 0 1 2 0 3 2 9 4 4 1
      • eBook
        9 7 8 0 0 8 0 5 8 1 3 5 4
      Drug–Drug Interactions is a comprehensive review of the scientific and regulatory perspectives of drug–drug interactions from the point-of-view of academia, industry, and government regulatory agencies. This book is intended for professionals in the pharmaceutical industry, health care, and governmental regulatory agencies. Topics of interest include the mechanistic understanding of drug–drug interactions, the prediction of drug–drug interaction potential of new drugs, and the avoidance of clinically significant drug–drug interaction in patients.

    • XIVth International Symposium on Medicinal Chemistry

      • 1st Edition
      • Volume 28
      • September 12, 1997
      • F. Awouters
      • English
      • Hardback
        9 7 8 0 4 4 4 8 2 7 9 8 2
      • eBook
        9 7 8 0 0 8 0 5 4 3 8 8 8
      Vaso-occlusive disorders including unstable angina, myocardial infarction, transient ischemic attacks, stroke and peripheral artery disease remain the major sources of morbidity and mortality in western civilization. Platelet activation and resulting platelet aggregation play a major role in the pathogenesis of these thromboembolic diseases. Recognition of the contribution of platelets to the pathophysiology of cardiovascular disease has provided impetus for the continued search for new antiplatelet agents. Hence, over the past two decades many strategies have been evaluated in the search for efficacious mechanisms to reduce platelet function. The medical need for more efficacious antithrombotic drugs and the growing understanding of the role of platelets in vascular injury have catalyzed the extensive evaluation of novel approaches to control platelet function. Along these lines, the volume therefore provides an in-depth assessment of ongoing clinical trials, new and clinically established agents, and other developments in this rapidly developing field.

Related subjects

Biochemical pharmacology

Cardiovascular pharmacology

Clinical pharmacology therapeutics

Clinical trials

Drug adverse reactions and interactions

Endocrine exocrine pharmacology

Ethnopharmacology

Gastrointestinal pharmacology

Immunopharmacology pharmacology

Molecular pharmacology

Neoplastic cancer pharmacology

Pharmacokinetics pharmacodynamics

Pharmacology general

Principles of pharmacology

Psychoneuropharmacology

Pulmonary pharmacology

Renal and electrolyte pharmacology